The view in the 1960s was that psychedelic drugs put users into an indolent, blissed-out state that encouraged them, in the words of an early booster, the one-time Harvard psychologist, Timothy Leary, to “turn on, tune in, drop out”.
”. Several other states, including conservative ones such as Texas, have approved medical research into psychedelics. America’s drugs regulator may approve, better known as Ecstasy, for treating post-traumatic stress disorder as early as next year, and has hailed psilocybin as a “breakthrough therapy” in treating severe depression. The European Medicines Agency is conducting large-scale trials of psilocybin to treat otherwise intractable depression.
The conditions that psychedelics seem to ameliorate include depression, addiction and post-traumatic stress disorder. Precisely how they work is unclear, which is one reason more research is required. Users report an increased sense of connectedness, a decrease in anxiety and a reduction in depressive symptoms. It seems that these benefits persist.
Good article guys, psilocybin and DMT proven science in neural plasticity warrants widespread controlled availability at least for those willing and suitable. DMT deserves far deeper interest as if anyone can work out what it does to consciousness deserves a Noble Prize. Rog.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: The Telegraph - 🏆 41. / 63 Read more »
Source: Daily Express - 🏆 26. / 68 Read more »
Source: The Mirror - 🏆 136. / 51 Read more »
Source: OK_Magazine - 🏆 12. / 84 Read more »
Source: TheEconomist - 🏆 6. / 92 Read more »
Source: AnOtherMagazine - 🏆 97. / 51 Read more »